患者遠隔モニタリング機器の世界市場：規模、シェア、動向分析（2025年～2031年）：MedCore

世界の患者遠隔モニタリング機器市場は、2024年には約51億米ドルとなりました。同市場は、10.3％のCAGRで拡大し、2031年には100億米ドル以上に達すると予測されています。

患者遠隔モニタリング機器システムにより、ヘルスケアプロバイダーは従来の医療環境以外でも患者の健康データを追跡することができ、患者の転帰を改善し、病院の再入院を減らすことができます。

当レポートでは、世界の患者遠隔モニタリング機器市場について調査し、市場の概要とともに、市場分析と予測、促進要因と抑制要因、競合情勢などを提供しています。

目次

エグゼクティブサマリー

• 世界の患者遠隔モニタリング機器市場概要
• 競合分析
• 市場セグメンテーション
• 対象地域

イントロダクション

• 患者遠隔モニタリング機器ソリューション
• 心臓埋め込み型電子機器
• 慢性閉塞性肺疾患
• 糖尿病
• 高血圧
• 心臓病

市場概要

• セグメント別
• 地域別

市場分析と予測

• 患者遠隔モニタリング機器市場全体
• 疾病管理市場
• 心臓埋込み型電子機器市場

促進要因と抑制要因

競合市場シェア分析

LIST OF CHARTS

• Chart 6-1: Remote Patient Monitoring Market, Global, 2024 & 2031
• Chart 6-2: Remote Patient Monitoring Units Sold, Global, 2024
• Chart 6-3: Remote Patient Monitoring Market by Segment, Global, 2021 - 2031
• Chart 6-4: Remote Patient Monitoring Market by Region, Global, 2021 - 2031
• Chart 6-5: Leading Competitors, Remote Patient Monitoring Market, Global, 2024

LIST OF FIGURES

• Figure 6-1: Remote Patient Monitoring Market Segmentation
• Figure 6-2: Remote Patient Monitoring Regions Covered, Global (1 of 2)
• Figure 6-3: Remote Patient Monitoring Regions Covered, Global (2 of 2)
• Figure 6-4: Remote Patient Monitoring Market by Segment, Global, 2021 - 2031 (US$M)
• Figure 6-5: Remote Patient Monitoring Market by Region, Global, 2021 - 2031 (US$M)
• Figure 6-6: Remote Patient Monitoring Market, Global, 2021 - 2031
• Figure 6-7: Units Sold by Region, Remote Patient Monitoring Market, Global, 2021 - 2031
• Figure 6-8: Average Selling Price by Region, Remote Patient Monitoring Market, Global, 2021 - 2031 (US$)
• Figure 6-9: Market Value by Region, Remote Patient Monitoring Market, Global, 2021 - 2031 (US$M)
• Figure 6-10: Total Disease Conditions Management Market, Global, 2021 - 2031
• Figure 6-11: Units Sold by Region, Disease Conditions Management Market, Global, 2021 - 2031
• Figure 6-12: Average Selling Price by Region, Disease Conditions Management Market, Global, 2021 - 2031 (US$)
• Figure 6-13: Market Value by Region, Disease Conditions Management Market, Global, 2021 - 2031 (US$M)
• Figure 6-14: Cardiac Implantable Electronic Device Market, Global, 2021 - 2031
• Figure 6-15: Units Sold by Region, Cardiac Implantable Electronic Device Market, Global, 2021 - 2031
• Figure 6-16: Average Selling Price by Region, Cardiac Implantable Electronic Device Market, Global, 2021 - 2031 (US$)
• Figure 6-17: Market Value by Region, Cardiac Implantable Electronic Device Market, Global, 2021 - 2031 (US$M)
• Figure 6-18: Leading Competitors, Remote Patient Monitoring Market, Global, 2024

The global remote patient monitoring market was valued at nearly $5.1 billion in 2024 and is projected to grow at a CAGR of 10.3%, reaching over $10 billion by 2031.

Remote patient monitoring systems allow healthcare providers to track patient health data outside of traditional healthcare settings, improving patient outcomes and reducing hospital readmissions.

The market is segmented into:

• Disease Conditions Management
• Cardiac Implantable Electronic Devices (CIED)
• Market Insights
• Unit Sales & Average Selling Prices
• Market Size & Growth Trends
• Market Drivers & Limiters
• Market Forecasts Until 2031
• Historical Data (2021-2023)
• Competitive Analysis
• Recent Mergers & Acquisitions
• Company Profiles & Product Portfolios

Market Trends

Key trends driving the market include:

• Increasing elderly population requiring continuous health monitoring
• Growing prevalence of chronic diseases such as cardiovascular disorders and diabetes
• Adoption of cloud-based telehealth platforms
• Integration of Wi-Fi, 4G, and 5G connectivity into RPM devices

Market Share Insights

Top Competitors in the Global Remote Patient Monitoring Market (2024):

1 Medtronic

* Market leader, primarily due to its partnership with the Veterans Health Administration's (VHA's) Care Coordination and Home Telehealth (CCHT) program.

2 Philips Healthcare

* Second-largest competitor, offering remote monitoring through its eCareCompanion(TM) platform, which connects via cellular or Wi-Fi networks to deliver cloud-based telehealth services.

3 Honeywell Life Sciences

* Third-largest competitor, offering the Genesis Touch(TM) v2 RPM device with 3G, 4G, and Wi-Fi connectivity. Honeywell also provides Genesis DM(TM) for symptom-specific management using voice-enabled DSSM tools.

Global Research Scope

• Regions Covered:

* North America: U.S., Canada

* Latin America: Brazil, Mexico, Argentina, etc.

* Western Europe: U.K., Germany, France, Spain, Italy, etc.

* Central & Eastern Europe: Russia, Poland, Turkey, etc.

* Middle East: Saudi Arabia, UAE, Israel, etc.

* Asia Pacific: China, Japan, India, Australia, etc.

* Africa: South Africa, Nigeria, Egypt, etc.

• Base Year: 2024
• Forecast Period: 2025-2031
• Historical Data: 2021-2023

Quantitative Coverage

• Market Size
• Market Shares
• Market Forecasts
• Market Growth Rates
• Units Sold
• Average Selling Prices

Qualitative Coverage

• COVID-19 Impact
• Market Growth Trends
• Market Limiters
• Competitive Analysis & SWOT for Top Competitors
• Mergers & Acquisitions
• Company Profiles
• Product Portfolios
• FDA Recalls
• Disruptive Technologies
• Disease Overviews

Data Sources

• Primary Interviews with Industry Leaders
• Government & Regulatory Data
• Hospital Private Data
• Import & Export Data
• iData Research Internal Database

TABLE OF CONTENT

Table of Contents

• 6.1 Executive Summary
  • 6.1.1 Global Remote Patient Monitoring Market Overview
  • 6.1.2 Competitive Analysis
  • 6.1.3 Market Segmentation
  • 6.1.4 Regions Included
• 6.2 Introduction
  • 6.2.1 Remote Patient Monitoring Solutions
  • 6.2.2 Cardiac Implantable Electronic Devices
  • 6.2.3 Chronic Obstructive Pulmonary Disease
  • 6.2.4 Diabetes
  • 6.2.5 Hypertension
  • 6.2.6 Heart Conditions
• 6.3 Market Overview
  • 6.3.1 By Segment
  • 6.3.2 By Region
• 6.4 Market Analysis and Forecast
  • 6.4.1 Total Remote Patient Monitoring Market
  • 6.4.2 Disease Conditions Management Market
  • 6.4.3 Cardiac Implantable Electronic Device Market
• 6.5 Drivers and Limiters
  • 6.5.1 Market Drivers
  • 6.5.2 Market Limiters
• 6.6 Competitive Market Share Analysis